Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
28.1M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
104K
-
Shares change
-
-444M
-
Total reported value, excl. options
-
$617K
-
Value change
-
-$181M
-
Number of sells
-
-78
-
Price
-
$5.96
Significant Holders of GeneDx Holdings Corp. - Class A Common Stock (WGS) as of Q2 2023
84 filings reported holding WGS - GeneDx Holdings Corp. - Class A Common Stock as of Q2 2023.
GeneDx Holdings Corp. - Class A Common Stock (WGS) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 104K shares
of 28.1M outstanding shares and own 0.37% of the company stock.
Largest 10 shareholders include Decheng Capital Management III (Cayman), LLC (104K shares), Versant Capital Management, Inc (0 shares), WELLS FARGO & COMPANY/MN (0 shares), Bayesian Capital Management, LP (0 shares), Evolution Wealth Advisors, LLC (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), Vanguard Personalized Indexing Management, LLC (0 shares), Legal & General Group Plc (0 shares), MORGAN STANLEY (0 shares), and WOLVERINE TRADING, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.